| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b2b1e4c6f6cf2ea6efa1a5b79d4b057
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a77b8cc427db284b23b54636b37e89a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b53290ef881bc16e92cfbaf0cd9605a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c0adc039de98f90e0e67dcc4eb6a5da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd2c3900689abdaedb13713965cfb0fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57d46efd85795ce5969a79f03a6a2c1b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2230-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-602 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06 |
| filingDate |
2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b2a3eac32b61efd68c5df15f0a1dba9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da962739c9c04843d64122eafb0f2292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2517d7390277e9080f08ff0489355b1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0857fa488c79b830e09d877e2bcab12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a3cb3d2a92238dffc2f927ea6bb652 |
| publicationDate |
2005-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004110302-A3 |
| titleOfInvention |
Methods of delivering anti-restenotic agents from a stent |
| abstract |
A method for decreasing the level of restenosis following a stent (10) placement medical intervention involves the continuous administration of a dose of an anti-restenotic agent, such as paclitaxel, from the stent to vascular tissue in need of treatment in a controlled, extended and substantially linear drug release profile. The method of substantially linear extended release increases the therapeutic effectiveness of administration of a given dosage. In one example, a method of reducing restenosis includes delivering paclitaxel from a stent (10) to an artery at a minimum release rate of 1 percent of the total dosage of paclitaxel on the stent (10) per day throughout an entire administration period from the time of implantation of the stent (10) until the time that substantially all the paclitaxel is released from the stent (10). |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106974751-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8900292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9456910-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9248034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8932346-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9284409-B2 |
| priorityDate |
2003-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |